The novel therapy of tirzepatide peptide represents a major advance in the handling of the condition. Unlike existing medications, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – providing greater glucose management and possible weight loss. Experts are investigating its future advantages and role in the complete treatment of di